Danish Novozymes 2014 net profit rises 15% on higher sales

Franco Capaldo

20-Jan-2015

Novozymes headquartersLONDON (ICIS)–Novozymes reported an annual increase in net profit of 15% to Danish kroner (DKr) 2.53bn ($341m) in 2014 on higher sales of DKr12.5bn, up 6% year on year, the Danish enzyme producer said on Tuesday.

Earnings before interest and taxes (EBIT) grew 17% to DKr3.38bn, resulting in an EBIT margin of 27.2% (up from 24.7% in 2013).

Novozymes said EBIT growth had driven net profit, although an increase in tax of around DKr200m did have a negative impact . The group’s effective tax rate in 2014 was 23.0%, against 20.2% in 2013 due to a lower benefit from a US Advanced Energy Manufacturing tax credit relating to its plant in Nebraska.

Peder Holk Nielsen, president and CEO of Novozymes, said: “2014 was a good year for Novozymes with 7% organic sales growth and a record EBIT margin. Bioenergy was the strongest growth driver, making up for slower growth in Food & Beverages and Household Care.”

“Long-term organic sales growth is expected to be slightly lower than the previous target, whereas we increase the long-term targets for EBIT margin and return on invested capital. In the midst of a slow recovery and volatile markets, we expect 2015 to be another good year for Novozymes,” he added.

In 2015, on the sales side, Novozymes expects organic sales growth of 7-9% and based on exchange rates on 19 January 2015, sales growth in DKr is expected to be 13-15%.

EBIT growth, meanwhile, this year is expected to be 12-14%, while net profit is expected to grow by 10-12%.

On Tuesday, Novozymes also outlined a strategy focused on partnerships to improve its innovation and updated long-term targets.

Through 2020, Novozymes targets annual organic sales growth of 8-10% in local currency on average (replacing a previous target of 10%) and an EBIT margin of 26% or more (replacing a previous target of 24% or more).

The company also published long-term operational targets for sustainability by 2020. This includes a 30% improvement in energy efficiency over 2014, a 25% improvement in water efficiency, a 25% reduction in CO2 intensity and 30% of its energy to come from renewable sources.

In addition, a new stock buyback program worth up to DKr2bn is set to run in 2015, it added.

Novozymes corporate headquarters

($1 = DKr7.43)

READ MORE

Global News + ICIS Chemical Business (ICB)

See the full picture, with unlimited access to ICIS chemicals news across all markets and regions, plus ICB, the industry-leading magazine for the chemicals industry.

Contact us

Partnering with ICIS unlocks a vision of a future you can trust and achieve. We leverage our unrivalled network of industry experts to deliver a comprehensive market view based on independent and reliable data, insight and analytics.

Contact us to learn how we can support you as you transact today and plan for tomorrow.

READ MORE